Company intelligence / Profile preview

Woodward Pharma Services

Wixom, Michigan, United Statespitchbook.com ↗

Ownership: Private
Development stage: Other

Overview

Woodward Pharma Services is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing branded and generic prescription drugs for the U.S. market. The company has recently commercialized a generic sodium acetate injection in partnership with Milla Pharmaceuticals/A.forall to address drug shortages. It also acquired LOVAZA (omega-3-acid ethyl esters), an FDA-approved therapy for severe hypertriglyceridemia. The pipeline includes both marketed and withdrawn products.

Therapeutic areas: Metabolic DisordersEndocrinologyCardiovascular
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Milla Pharmaceuticals/A.forall

Beyond the preview

Go deeper on Woodward Pharma Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Woodward Pharma Services.

Explore the full profile